1. Home
  2. ZLAB vs CDNA Comparison

ZLAB vs CDNA Comparison

Compare ZLAB & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$26.49

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$56.41

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZLAB
CDNA
Founded
2013
1998
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.6B
IPO Year
2017
2007

Fundamental Metrics

Financial Performance
Metric
ZLAB
CDNA
Price
$26.49
$56.41
Analyst Decision
Strong Buy
Buy
Analyst Count
5
6
Target Price
$49.60
$28.00
AVG Volume (30 Days)
781.7K
998.0K
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
38.46
N/A
EPS
N/A
2.13
Revenue
$460,156,000.00
$48,324,000.00
Revenue This Year
$9.75
$16.01
Revenue Next Year
$26.03
$11.31
P/E Ratio
N/A
$25.51
Revenue Growth
15.33
18.93
52 Week Low
$15.96
$13.95
52 Week High
$34.72
$55.16

Technical Indicators

Market Signals
Indicator
ZLAB
CDNA
Relative Strength Index (RSI) 62.61 69.63
Support Level $16.84 $45.74
Resistance Level $27.22 N/A
Average True Range (ATR) 0.88 1.91
MACD -0.05 -0.01
Stochastic Oscillator 80.44 86.71

Price Performance

Historical Comparison
ZLAB
CDNA

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: